Literature DB >> 2863522

Disappearing collagen antibodies in rheumatoid arthritis.

R S Pereira, C M Black, V C Duance, V E Jones, R K Jacoby, K I Welsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2863522     DOI： 10.1016/s0140-6736(85)90436-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  What do anti-collagen antibodies mean?

Authors:  K Morgan
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

2.  B cell-deficient mice do not develop type II collagen-induced arthritis (CIA).

Authors:  L Svensson; J Jirholt; R Holmdahl; L Jansson
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

3.  Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis.

Authors:  Yanpeng Li; Dongmei Tong; Peibin Liang; Erik Lönnblom; Johan Viljanen; Bingze Xu; Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2020-05-24       Impact factor: 5.156

4.  Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis?

Authors:  N P Bakker; M G van Erck; C Zurcher; P Faaber; A Lemmens; M Hazenberg; R E Bontrop; M Jonker
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Activity of rheumatoid arthritis and levels of collagen antibodies: a prospective study.

Authors:  A Stockman; M J Rowley; P Emery; K D Muirden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

6.  Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis.

Authors:  Mohammed Mullazehi; Marius C Wick; Lars Klareskog; Ronald van Vollenhoven; Johan Rönnelid
Journal:  Arthritis Res Ther       Date:  2012-05-01       Impact factor: 5.156

7.  Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.

Authors:  Vivek Anand Manivel; Mohammed Mullazehi; Leonid Padyukov; Helga Westerlind; Lars Klareskog; Lars Alfredsson; Saedis Saevarsdottir; Johan Rönnelid
Journal:  Ann Rheum Dis       Date:  2017-03-23       Impact factor: 19.103

8.  Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons.

Authors:  Alex Bersellini Farinotti; Gustaf Wigerblad; Diana Nascimento; Rikard Holmdahl; Camilla I Svensson; Duygu B Bas; Carlos Morado Urbina; Kutty Selva Nandakumar; Katalin Sandor; Bingze Xu; Sally Abdelmoaty; Matthew A Hunt; Kristina Ängeby Möller; Azar Baharpoor; Jon Sinclair; Kent Jardemark; Johanna T Lanner; Ia Khmaladze; Lars E Borm; Lu Zhang; Fredrik Wermeling; Mark S Cragg; Johan Lengqvist; Anne-Julie Chabot-Doré; Luda Diatchenko; Inna Belfer; Mattias Collin; Kim Kultima; Birgitta Heyman; Juan Miguel Jimenez-Andrade; Simone Codeluppi
Journal:  J Exp Med       Date:  2019-06-13       Impact factor: 14.307

9.  Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis.

Authors:  Andrew D Cook; Robyn Gray; John Ramshaw; Ian R Mackay; Merrill J Rowley
Journal:  Arthritis Res Ther       Date:  2004-08-11       Impact factor: 5.156

10.  Granulocyte-augmented chemokine production induced by type II collagen containing immune complexes is mediated via TLR4 in rheumatoid arthritis patients.

Authors:  Vivek Anand Manivel; Azita Sohrabian; Johan Rönnelid
Journal:  Eur J Immunol       Date:  2016-10-05       Impact factor: 5.532
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.